Research, Development, And Testing Services - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Research, Development, And Testing Services - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Research, Development, And Testing Services
Corporate Insider Buy Sell Ratio (Insider Count) - Research, Development, And Testing Services
Research, Development, And Testing Services - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.791 -2,495
2024-12-09 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A S - Sale D 4.13 -23,871
2024-12-09 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W S - Sale D 4.13 -13,634
2024-12-09 OABI / OmniAb, Inc. 4 Berkman Charles S S - Sale D 4.13 -8,022
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.932 483
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 891
2024-12-09 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 1.641 1,121
2024-12-09 INCY / Incyte Corporation 4 SWAIN PAULA J F - Taxes D 72.11 -873
2024-12-09 INCY / Incyte Corporation 4 Flannelly Barry P F - Taxes D 72.11 -1,510
2024-12-07 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 26,555
2024-12-07 OABI / OmniAb, Inc. 4 GUSTAFSON KURT A M - Exercise D 46,501
2024-12-07 OABI / OmniAb, Inc. 4 Berkman Charles S M - Exercise D 15,621
2024-12-07 NEO / NeoGenomics, Inc. 4 Sherman Jeffrey Scott F - Taxes D -11,746
2024-12-06 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.701 -505
2024-12-06 NOTV / Inotiv, Inc. 4 Harrington Michael J P - Purchase D 3.9822 10,000
2024-12-06 NOTV / Inotiv, Inc. 4 Landman David P - Purchase D 4.14 100,000
2024-12-06 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 505
2024-12-06 MEDP / Medpace Holdings, Inc. 4 GEIGER JESSE J M - Exercise D 32.05 15,000
2024-12-03 IQV / IQVIA Holdings Inc. 4 DANHAKL JOHN G By LLC P - Purchase I 200.58 1,275
2024-12-01 NEO / NeoGenomics, Inc. 4 Stone Warren F - Taxes D -6,224
2024-11-30 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 3.05 -5,194
2024-11-29 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 75.37 -5,683
2024-11-29 INCY / Incyte Corporation 4 Iyengar Vijay K S - Sale D 75.60 -360
2024-11-25 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 3.75 68,360
2024-11-25 OABI / OmniAb, Inc. 4 FOEHR MATTHEW W M - Exercise D 3.68 31,074
2024-11-20 ONMD / OneMedNet Corporation 4 Casaburi Eric P - Purchase D 0.87 1,300
2024-11-19 MEDP / Medpace Holdings, Inc. 4 BURWIG SUSAN E M - Exercise D 32.05 7,500
2024-11-15 NEO / NeoGenomics, Inc. 4 Olivo Alicia C S - Sale D 15.3575 -5,175
2024-11-12 ONMD / OneMedNet Corporation 4 Casaburi Eric P - Purchase D 0.85 500
2024-11-08 CRL / Charles River Laboratories International, Inc. 4 FOSTER JAMES C G - Gift D -4,500
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F By Wife S - Sale I 216.50 -1,000
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F S - Sale D 215.75 -3,371
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F S - Sale D 216.50 -3,250
2024-11-07 CRL / Charles River Laboratories International, Inc. 4 Barbo William D By Trust G - Gift I -470
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 78.21 -2,256
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P S - Sale D 82 -1,424
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P M - Exercise D 68.62 2,256
2024-11-06 INCY / Incyte Corporation 4 Flannelly Barry P M - Exercise D 72.27 1,424
2024-11-06 CRL / Charles River Laboratories International, Inc. 4 WALLMAN RICHARD F G - Gift D -4,540
2024-11-05 BIAF / bioAffinity Technologies, Inc. 4 Edwards James Michael A - Award D 100,000
2024-11-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C S - Sale D 3.72 -47,689
2024-11-01 OABI / OmniAb, Inc. 4 Bertozzi Carolyn R M - Exercise D 17,769
2024-11-01 OABI / OmniAb, Inc. 4 Love Steven M - Exercise D 13,333
2024-11-01 MXCT / MaxCyte, Inc. 4 Erck Stanley C M - Exercise D 0.04 47,689
2024-10-28 MXCT / MaxCyte, Inc. 4 Johnston John Joseph S - Sale D 3.722 -3,000
2024-10-28 MXCT / MaxCyte, Inc. 4 Johnston John Joseph M - Exercise D 2.926 3,000
2024-10-16 LUNA / Luna Innovations Incorporated 4 Phelan William Lawrence A - Award D 150,000
2024-10-14 MXCT / MaxCyte, Inc. 4 Collins Cynthia A - Award D 51,679
2024-10-12 ABSI / Absci Corporation 4 Busch Andreas F - Taxes D 4.07 -3,092
2024-10-12 ABSI / Absci Corporation 4 Jonasson Zachariah F - Taxes D 4.07 -242
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)